Navigation Links
Caution Urged in Intensive Treatment of Type 2 Diabetes
Date:7/27/2011

WEDNESDAY, July 27 (HealthDay News) -- Intensive glucose-lowering treatment for people with type 2 diabetes doesn't reduce the risk of cardiovascular-related death and doctors need to be cautious about prescribing this type of treatment, a new study suggests.

Patients with type 2 diabetes are at increased risk for cardiovascular disease. Intensive glucose-lowering treatment is widely used for these patients even though previous research hasn't shown any clear benefits, the researchers pointed out in a report published in the July 27 online edition of the BMJ.

In the new study, Catherine Cornu, a research physician at the Clinical Investigation Centre, Louis Pradel Hospital in Bron, France, and colleagues reviewed 13 studies that included a total of 34,533 diabetes patients -- 18,315 who underwent intensive glucose-lowering treatment and 16,218 who received standard treatment.

Intensive treatment did not significantly reduce cardiovascular death or all-cause death, but it was associated with a 15 percent reduced risk of non-fatal heart attacks and a 10 percent reduced risk of microalbuminuria, an indicator of kidney problems and heart disease, the researchers found.

But, intensive treatment was also linked with a more than twofold increase in the risk of dangerously low blood glucose levels (severe hypoglycemia), the investigators noted in a journal news release.

Over a five-year treatment period, 117 to 150 patients would need to undergo intensive glucose-lowering treatment to prevent one heart attack, 32 to 142 patients would have to be treated to prevent one case of microalbuminuria, and 15 to 52 would need to be treated to avoid one severe hypoglycemic event, the researchers calculated.

"Intensive glucose-lowering treatment of type 2 diabetes should be considered with caution and therapeutic escalation should be limited," the authors concluded.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about type 2 diabetes.

-- Robert Preidt

SOURCE: BMJ, news release, July 26, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. People with prediabetes not taking adequate precautions to avoid diabetes
2. ATV and motocross sports - high velocity toys merit caution
3. New York Medical Malpractice Attorney Recommends Cancer Patients Take Precautionary Steps Before Undergoing Radiation Therapy
4. Study cautions: Psychotropic medications overprescribed to children
5. As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution
6. As Autism Web Sites Boom, Experts Urge Caution
7. SNM cautions that Canadas Chalk River coming back online will not solve long-term isotope shortage
8. New guideline from ASH and ASCO recommends caution regarding ESA use in cancer patients
9. Use Anemia Drugs for Cancer Patients With Caution, Experts Say
10. Docs Claim Transplant Cured Man of HIV, But Experts Urge Caution
11. Take Safety Precautions in the Snow, Ice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Caution Urged in Intensive Treatment of Type 2 Diabetes 
(Date:9/26/2017)... ... , ... “Sound of My Song”: an intriguing and thought-provoking on love, life, ... a retired teacher with a passion for music and ancestral history. , Published ... on loss, living with depression, and finding love through the journey. There is powerful ...
(Date:9/26/2017)... ... 26, 2017 , ... “The Great Creator Saves Boobie and Ceebie”: a tool families can use ... Ceebie” is the creation of published author, G.S. White, a devoted follower of Jesus Chris ... Jersey. , “This book is not only for children but also to glorified God ...
(Date:9/25/2017)... ... September 25, 2017 , ... The ... the addition of an affiliate in Minneapolis-St. Paul, MN, Dr. Adam Locketz. Dr. ... Naltrexone therapy and aftercare planning through his Timewise Medical practice in the twin ...
(Date:9/25/2017)... ... September 25, 2017 , ... Nissar A. Darmani, PhD, has ... cancer patients suffering from chemotherapy-evoked nausea and vomiting. Dr. Darmani is Associate Dean ... , The five-year grant is from the National Cancer Institute (NCI) arm of ...
(Date:9/25/2017)... ... September 25, 2017 , ... Order Custom Tee Shirts Online ... No need to be concerned about garment selection, expensive graphic designers, substandard printing, ... are printed and shipped within 5-10 days. And every garment we ship ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: